Login / Signup

Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A systematic review.

Péter HegyiPéter Jenő HegyiNelli FarkasPéter HegyiMárta BalaskóAdrienn ErősSzabina SzujóJudit PammerBernadett MosdósiMária SimonArnold NagyGabriella FűrAlizadeh Hussain
Published in: PloS one (2020)
Malformations affected, on average 2.5% of live births from fathers who did not discontinue TKI treatment before conception, which is comparable with the rate of malformations in the general population. Large-scale studies with representative samples are awaited to confirm our results.
Keyphrases
  • pregnancy outcomes
  • chronic myeloid leukemia
  • pregnant women
  • young adults
  • cross sectional
  • metabolic syndrome
  • gestational age
  • adipose tissue
  • replacement therapy
  • breast cancer risk